Knoll Capital Management, LLC
MIAMI, FL · CIK 1325083 · 13F filing filed 2025-02-18
No investment adviser registration (Form ADV) found for this filer. It may be a parent company whose subsidiaries are the registered advisers, a bank or insurer, or a manager based outside the US.
- Others nearbyMiami, FL
$155.3m
reported value
-28.0% vs Q3 2024
35positions
75.5%in top 10
0 new
3 added
3 reduced
1 sold out
vs Q3 2024
Holdings, Q4 2024
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| BIOHAVEN PHARMACTL HLDG CO L BHVN | $28.4m18.28% | Added +50.0k |
| ALDEYRA THERAPEUTICS INC ALDX | $27.3m17.59% | Unchanged |
| ENTERA BIO LTD ENTX | $12.5m8.03% | Added +2.0m |
| VERONA PHARMA PLC VRNA | $9.3m5.98% | Unchanged |
| ALTIMMUNE INC ALT | $8.1m5.21% | Unchanged |
| SPDR GOLD TR GLD | $7.7m4.99% | Unchanged |
| MEIRAGTX HLDGS PLC MGTX | $7.6m4.90% | Unchanged |
| AVADEL PHARMACEUTICALS PLC SPONSORED ADR | $6.3m4.06% | Unchanged |
| OCULAR THERAPEUTIX INC OCUL | $5.1m3.30% | Unchanged |
| APPLIED THERAPEUTICS INC APLT | $5.0m3.20% | Added +225.0k |
| AGNICO EAGLE MINES LTD AEM | $4.3m2.79% | Unchanged |
| KINROSS GOLD CORP KGC | $4.1m2.63% | Unchanged |
| SEABRIDGE GOLD INC COM | $3.6m2.33% | Unchanged |
| FRANCO NEV CORP FNV | $2.9m1.89% | Unchanged |
| EQUINOX GOLD CORP EQX | $2.8m1.78% | Unchanged |
| SKEENA RES LTD NEW SKE | $2.8m1.77% | Unchanged |
| MAG SILVER CORP MAG | $2.3m1.49% | Unchanged |
| ISHARES SILVER TR SLV | $2.1m1.36% | Unchanged |
| BOOZ ALLEN HAMILTON HLDG COR BAH | $1.7m1.08% | Unchanged |
| VISA INC V | $1.5m0.99% | Unchanged |
| PHILIP MORRIS INTL INC PM | $1.2m0.77% | Unchanged |
| ISHARES TR ITA | $1.1m0.72% | Unchanged |
| NORTHROP GRUMMAN CORP NOC | $1.0m0.65% | Unchanged |
| HOOKIPA PHARMA INC COM | $1.0m0.65% | Reduced -53.1k |
| ROYAL GOLD INC RGLD | $995.5k0.64% | Unchanged |
| MEREO BIOPHARMA GROUP PLC MREO | $911.6k0.59% | Unchanged |
| DIAGEO PLC DEO | $858.1k0.55% | Unchanged |
| ALAMOS GOLD INC NEW AGI | $756.0k0.49% | Unchanged |
| WHEATON PRECIOUS METALS CORP WPM | $703.0k0.45% | Unchanged |
| NEW PAC METALS CORP NEWP | $572.3k0.37% | Unchanged |
| SILVERCREST METALS INC SIL | $546.0k0.35% | Unchanged |
| CARDIOL THERAPEUTICS INC CRDL | $128.0k0.08% | Unchanged |
| Orgenesis, Inc. COM | $95.7k0.06% | Reduced -12.8k |
| GRAIL INC GRAL | $1.8k0.00% | Unchanged |
| OPUS GENETICS INC IRD | $530.00% | Reduced -100.0k |
Sold out since Q3 2024
| Security | Value then |
|---|---|
| CVS HEALTH CORP CVS | $911.8k14.5k shares |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| ELICIO THERAPEUTICS INC ELTX · 13G · filed 2026-07-08 | 5.3%≈ $4.7m |